Cadent Capital Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$404K Buy
1,117
+8
+0.7% +$2.74K 0.08% 134
2026
Q1
$390K Buy
1,109
+1
+0.1% +$356 0.1% 121
2025
Q4
$363K Buy
1,108
+1
+0.1% +$317 0.09% 129
2025
Q3
$312K Buy
+1,107
New +$321K 0.08% 147

Other funds holding AMGN

Cadent Capital Advisors's AMGN Position: Q2 2026 in Review

Cadent Capital Advisors increased its Amgen (AMGN) stake by 0.72% in Q2 2026, buying an estimated $2.74K and bringing the position to 1,117 shares worth $404K. The position accounts for 0.08% of the portfolio, ranked #134.

Cadent Capital Advisors first reported a position in AMGN in Q3 2025 and has held it in 4 quarters since. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Cadent Capital Advisors held 1,117 shares of Amgen worth $404K as of Q2 2026.
  • Cadent Capital Advisors bought 8 Amgen shares in Q2 2026, an estimated $2.74K.
  • Amgen made up 0.08% of Cadent Capital Advisors's portfolio in Q2 2026, its #134 holding.
  • Cadent Capital Advisors first reported a position in Amgen in Q3 2025 and has held it in 4 quarters since.
  • 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Cadent Capital Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.